Government and APBI fail to reach agreement on cost of branded medicines The levy paid to the government on the sales of branded medicines to the NHS is higher than the rates paid in other countries, such as Ireland, Belgium, Germany and France.…
Medicines derived from UK blood plasma distributed to NHS hospitals for ‘first time in a generation’ More than 250,000 litres of plasma from UK donors have been sent to human protein product manufacturer Octapharma to produce NHS medicines for the first time since a 1998 ban.…
Medicines pricing system creating ‘false economy’ that drives shortages, says CCA report A report published by the Company Chemists’ Association found that the number of price concessions granted for generic medicines increased by over 740% from 2015 to 2024.…
UK medicines market ‘broken’ as levy on sales of branded medicines doubles, says ABPI The Department of Health and Social Care‘s proposals for the review of the statutory scheme for branded medicines would see a sharp increase in payments for the rest of the current year.…
UK medicines regulation disincentivising investment in research development, finds survey The Association of the British Pharmaceutical Industry’s survey results accompany 12 recommendations for improving the Medicines and Healthcare Products Regulatory Agency’s effectiveness as a UK medicines regulator.…
NHS England seeks views on centralising flu vaccine procurement NHS England says it wants to hear evidence of the benefits and challenges of a centralised procurement model in order to improve the effectiveness of the delivery of the flu vaccination programme.…
PJ view: Reshoring medicine manufacturing must be considered as an option for managing shortages With the number of medicine shortages on the rise, the UK government and pharmaceutical industry must review the idea of reshoring supply chains to minimise the impact on patients.…
Will reshoring medicines manufacturing solve shortages in the UK? In the United States and some European countries, drug manufacturing is being brought home to mitigate shortages of critical medicines, but would similar action in the UK shore up supply resilience?…
UK should be a ‘stronger destination’ for medicine manufacturers, says Wes Streeting The shadow health secretary said the NHS was not realising “anywhere near the full potential” of partnering with the life sciences industry on clinical trials and adopting and rolling out new treatments.…
Varenicline planned for return but ‘not before’ end of 2024, says manufacturer Pfizer has said smoking cessation therapy varenicline will be reintroduced to the UK, after being withdrawn in October 2021.…
